Your browser doesn't support javascript.
loading
Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?
Schebb, Nils Helge; Kühn, Hartmut; Kahnt, Astrid S; Rund, Katharina M; O'Donnell, Valerie B; Flamand, Nicolas; Peters-Golden, Marc; Jakobsson, Per-Johan; Weylandt, Karsten H; Rohwer, Nadine; Murphy, Robert C; Geisslinger, Gerd; FitzGerald, Garret A; Hanson, Julien; Dahlgren, Claes; Alnouri, Mohamad Wessam; Offermanns, Stefan; Steinhilber, Dieter.
Afiliação
  • Schebb NH; Chair of Food Chemistry, Faculty of Mathematics and Natural Sciences, University of Wuppertal, Wuppertal, Germany.
  • Kühn H; Department of Biochemistry, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Kahnt AS; Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany.
  • Rund KM; Chair of Food Chemistry, Faculty of Mathematics and Natural Sciences, University of Wuppertal, Wuppertal, Germany.
  • O'Donnell VB; School of Medicine, Systems Immunity Research Institute, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Flamand N; Département de Médecine, Faculté de Médecine, Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Canada Excellence Research Chair on the Microbiome-Endocannabinoidome Axis in Metabolic Health (CERC-MEND), Université Laval, Québec, QC, Canada.
  • Peters-Golden M; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, United States.
  • Jakobsson PJ; Rheumatology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Weylandt KH; Division of Medicine, Department of Gastroenterology, Metabolism and Oncology, Ruppin General Hospital, Brandenburg Medical School, Neuruppin, Germany.
  • Rohwer N; Division of Medicine, Department of Gastroenterology, Metabolism and Oncology, Ruppin General Hospital, Brandenburg Medical School, Neuruppin, Germany.
  • Murphy RC; Department of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Geisslinger G; Department of Pharmacology, University of Colorado-Denver, Aurora, CO, United States.
  • FitzGerald GA; Institute of Clinical Pharmacology, Pharmazentrum Frankfurt, University Hospital of Goethe-University, Frankfurt, Germany.
  • Hanson J; Fraunhofer Institute for Translational Medicine and Pharmacology, ITMP and Fraunhofer Cluster of Excellence for Immune Mediated Diseases, CIMD, Frankfurt, Germany.
  • Dahlgren C; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Alnouri MW; Laboratory of Molecular Pharmacology, GIGA-Molecular Biology of Diseases, University of Liège, Liège, Belgium.
  • Offermanns S; Laboratory of Medicinal Chemistry, Centre for Interdisciplinary Research on Medicines (CIRM), University of Liège, Liège, Belgium.
  • Steinhilber D; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Front Pharmacol ; 13: 838782, 2022.
Article em En | MEDLINE | ID: mdl-35308198

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article